TABLE 2—
Hepatitis C Testing and Infection by Race/Ethnicity, Socioeconomic, and Hepatitis C Risk Factors: Racial and Ethnic Approaches to Community Health Across the US Risk Factor Survey, 2009–2010
| Non-Hispanic Black |
Hispanic |
Asian |
American Indian/Alaska Native |
|||||||||
| Characteristics | Total, No. | Tested,No. (%) | HCV Positive,a % | Total, No. | Tested,No. (%) | HCV Positive,a % | Total, No. | Tested,No. (%) | HCV Positive,a % | Total, No. | Tested,No. (%) | HCV Positive,a % |
| Gender | ||||||||||||
| Female | 12 165 | 2328 (19.1) | 7.6 | 8273 | 1366 (16.5) | 6.7 | 5098 | 823 (16.1) | 5.5 | 2957 | 678 (22.9) | 5.9 |
| Male | 9515 | 2163 (22.7) | 10.9 | 8210 | 1483 (18.1) | 9.8 | 4871 | 940 (19.3) | 8.1 | 2799 | 701 (25.0) | 6.7 |
| Age, y | ||||||||||||
| 18–34 | 6487 | 1592 (24.5) | 2.3 | 6270 | 1098 (17.5) | 3.5 | 2843 | 478 (16.8) | 2.5 | 1915 | 493 (25.7) | 2.8 |
| 35–44 | 3470 | 892 (25.7) | 2.3 | 3764 | 664 (17.6) | 5.7 | 1995 | 419 (21.0) | 5.0 | 1064 | 334 (31.4) | 6.0 |
| 45–54 | 3836 | 877 (22.9) | 13.6 | 2613 | 524 (20.1) | 14.5 | 1834 | 362 (19.7) | 8.3 | 1075 | 297 (27.6) | 11.4 |
| 55–64 | 3993 | 778 (19.4) | 24.9 | 2255 | 386 (17.1) | 17.1 | 1704 | 287 (16.8) | 11.8 | 949 | 177 (18.6) | 8.5 |
| ≥ 65 | 3737 | 329 (8.8) | 13.7 | 1520 | 169 (11.1) | 10.6 | 1486 | 202 (13.6) | 11.4 | 740 | 77 (10.4) | 6.5 |
| Education level | ||||||||||||
| < high school | 3346 | 549 (16.4) | 18.0 | 4641 | 627 (13.5) | 12.7 | 1173 | 187 (15.9) | 12.8 | 869 | 186 (21.4) | 9.1 |
| High school graduate | 6678 | 1282 (19.2) | 11.2 | 4905 | 761 (15.5) | 8.8 | 2110 | 281 (13.3) | 9.2 | 2073 | 429 (20.7) | 7.7 |
| Some college | 6897 | 1608 (23.3) | 7.5 | 4109 | 863 (21.0) | 6.0 | 2416 | 425 (17.6) | 8.2 | 1748 | 475 (27.2) | 6.5 |
| College graduate | 4637 | 1039 (22.4) | 4.5 | 2740 | 583 (21.3) | 6.0 | 4223 | 866 (20.5) | 3.9 | 1052 | 289 (27.5) | 2.1 |
| Annual household income, $ | ||||||||||||
| < 25 000 | 10 176 | 2140 (21.0) | 12.6 | 7682 | 1309 (17.0) | 10.8 | 2850 | 429 (15.1) | 11.9 | 2364 | 614 (26.0) | 10.4 |
| 25 000–49 999 | 5363 | 1120 (20.9) | 7.2 | 4169 | 737 (17.7) | 6.2 | 2272 | 373 (16.4) | 8.0 | 1570 | 344 (21.9) | 3.5 |
| 50 000–74 999 | 2116 | 467 (22.0) | 6.0 | 1643 | 290 (17.6) | 6.2 | 1419 | 260 (18.3) | 6.1 | 719 | 172 (23.9) | 3.5 |
| ≥ 75 000 | 2416 | 562 (23.3) | 3.4 | 1799 | 362 (20.1) | 4.6 | 2692 | 608 (22.6) | 2.9 | 779 | 201 (25.8) | 2.0 |
| Health insurance | ||||||||||||
| No | 5023 | 1140 (22.7) | 8.3 | 4402 | 558 (12.7) | 4.5 | 1420 | 213 (15.0) | 8.4 | 1702 | 451 (26.5) | 7.1 |
| Yes | 16 344 | 3299 (20.2) | 9.4 | 11 892 | 2263 (19.0) | 9.1 | 8423 | 1529 (18.1) | 6.5 | 3969 | 906 (22.8) | 5.8 |
| Born in the United States | ||||||||||||
| No | 2018 | 356 (17.6) | 3.9 | 7986 | 1122 (14.0) | 8.2 | 6697 | 1299 (19.4) | 7.5 | 49 | 8 (16.3) | 0.0 |
| Yes | 19 580 | 4128 (21.1) | 9.7 | 8402 | 1721 (20.5) | 8.3 | 3253 | 462 (14.2) | 4.5 | 5699 | 1371 (24.1) | 6.3 |
| Hepatitis C risk factors (yes)b | ||||||||||||
| Injection drug use | 160 | 109 (68.1) | 77.1 | 90 | 61 (67.8) | 78.7 | 29 | 10 (34.5) | 20.0 | 77 | 46 (59.7) | 32.6 |
| Blood transfusion before 1992 | 408 | 116 (28.4) | 37.9 | 222 | 76 (34.2) | 38.2 | 141 | 39 (27.6) | 15.4 | 157 | 46 (29.3) | 8.7 |
| Blood transfusion outside the United States | 49 | 11 (22.4) | 18.2 | 73 | 27 (37.0) | 48.1 | 97 | 29 (29.9) | 27.5 | 11 | 4 (36.4) | 0.0 |
| Sexual contact with hepatitis positive person | 140 | 78 (55.7) | 43.6 | 96 | 57 (59.4) | 31.6 | 96 | 40 (41.7) | 2.5 | 59 | 31 (52.5) | 25.8 |
| Any of the above but unspecified | 158 | 80 (50.6) | 33.7 | 78 | 31 (39.4) | 41.9 | 44 | 17 (38.6) | 17.6 | 58 | 24 (41.4) | 33.3 |
Note. HCV = hepatitis C virus. Numbers might not add up to total because of missing responses; all percentages are weighted percentages. All the data are self-reported.
a
Of those tested for hepatitis C.
b
Risk factor information was collected in 2010 only (n = 29 727), and numbers refer to people who answered “yes” to a hepatitis C risk factor.